Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Top Stock Picks from Analysts

Hong Kong Pharmaceuticals & Biotech Top Stock Picks from Analysts

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are more than 50% undervalued based on analyst price target.

26 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
1177 Sino Biopharmaceutical	HK$2.97	5.3%	-0.7%	HK$54.0b	HK$4.48	PE23.6x	E12.8%	1.9%
1093 CSPC Pharmaceutical Group	HK$4.57	2.5%	-23.7%	HK$52.6b	HK$7.04	PE9.5x	E1.5%	6.9%
1548 Genscript Biotech	HK$10.86	1.7%	-19.7%	HK$23.3b	HK$22.72	PS3x	E111.3%	0%
512 Grand Pharmaceutical Group	HK$4.38	3.8%	28.4%	HK$15.3b	HK$6.63	PE6.4x	E2.3%	5.9%
9995 RemeGen	HK$13.90	4.7%	-23.3%	HK$13.2b	HK$25.04	PS4.6x	E51.9%	n/a
6826 Shanghai Haohai Biological Technology	HK$25.45	2.6%	3.4%	HK$12.9b	HK$42.57	PE12.7x	E16.8%	3.4%
2005 SSY Group	HK$3.22	1.9%	-23.0%	HK$9.5b	HK$5.74	PE7x	E6.6%	5.6%
2162 Keymed Biosciences	HK$31.65	7.3%	0%	HK$8.7b	HK$54.74	PS100x	E13.4%	n/a
2186 Luye Pharma Group	HK$2.12	1.9%	-18.5%	HK$8.0b	HK$3.45	PE9.7x	E14.4%	0%
6660 AIM Vaccine	HK$5.80	0%	-11.3%	HK$7.0b	HK$11.05	PS5.6x	S48.4%	n/a
2877 China Shineway Pharmaceutical Group	HK$8.65	4.5%	7.9%	HK$6.5b	HK$13.01	PE5.5x	E5.5%	6.5%
2563 Beijing Biostar Pharmaceuticals	HK$15.60	-4.6%	n/a	HK$5.7b	HK$35.84	PS79.9x	E57.6%	n/a
2157 Lepu Biopharma	HK$2.76	1.1%	-15.6%	HK$4.7b	HK$5.00	PS21.6x	S65.6%	n/a
2179 Jiangsu Recbio Technology	HK$8.32	0.4%	-5.5%	HK$4.0b	HK$13.00	PS86x	E45.0%	n/a
1477 Ocumension Therapeutics	HK$4.21	-3.0%	-17.3%	HK$3.4b	HK$8.35	PS10.4x	E97.2%	n/a
2315 Biocytogen Pharmaceuticals (Beijing)	HK$7.69	-2.3%	-6.4%	HK$3.1b	HK$13.49	PS3.6x	S22.4%	n/a
2256 Abbisko Cayman	HK$4.90	1.7%	114.9%	HK$3.1b	HK$9.16	PS5.8x	E-41.7%	n/a
2576 Zhejiang Taimei Medical Technology	HK$3.60	7.8%	n/a	HK$2.0b	HK$6.59	PS3.3x	S13.6%	n/a
1541 ImmuneOnco Biopharmaceuticals (Shanghai)	HK$4.86	-5.8%	-75.1%	HK$2.0b	HK$16.40	PS254.2x	S-81.8%	n/a
1061 Essex Bio-Technology	HK$2.61	-9.4%	9.7%	HK$1.5b	HK$5.12	PE5.6x	E6.2%	4.6%
2487 Cutia Therapeutics	HK$4.04	-7.3%	-33.7%	HK$1.3b	HK$14.61	PS6.1x	E49.4%	n/a
6622 Zhaoke Ophthalmology	HK$1.34	-3.6%	-21.2%	HK$731.8m	HK$2.50	PS12x	E11.7%	n/a
2126 JW (Cayman) Therapeutics	HK$1.41	1.4%	-25.4%	HK$570.5m	HK$2.40	PS3.1x	E-1.8%	n/a
6996 Antengene	HK$0.76	-2.6%	-37.7%	HK$516.4m	HK$1.33	PS8.6x	E16.8%	n/a

Page 1 of 2